Latest in News & Research
Featured Poster: Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib through Week 48 in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
In this poster presented at the 2023 Fall Clinical Dermatology Conference for PAs & NPs in Orlando, Piliang and colleagues evaluate scalp, eyebrow, and...
Featured Poster: Eyebrows and Eyelashes Regrowth Across Different SALT Response Thresholds in Patients with Alopecia Areata: Outcomes from the BRAVE AA Clinical Program
In this poster presented at the 2023 Fall Clinical Dermatology Conference for PAs & NPs in Orlando, Senna and colleagues analyze eyebrow and eyelash...
Featured Poster: Combining the 31-Gene Expression Profile Test for Cutaneous Melanoma with the American Joint Committee on Cancer Staging Identifies the Highest-Risk Patients with Stage I-II Disease
In this poster presented at the 2023 Fall Clinical Dermatology Conference for PAs & NPs in Orlando, Hyams and colleagues explore use of the...
Featured Poster: Dupilumab Improves Urticaria Signs and Symptoms and Quality of Life in Patients with Chronic Spontaneous Urticaria
In this poster presented at the 2023 Fall Clinical Dermatology Conference for PAs & NPs in Orlando, Maurer and colleagues present data from a...
Maldistribution of Dermatologists Persisted in 2021
71.6 percent of 712 populated zip codes with dermatologists have fewer than four dermatologists per 100,000
Do SCCs Have Worse Prognostic Features in Organ Transplant Recipients?
Organ transplant recipients have increased prevalence of poorly versus well-differentiated SCCs, and of tumors >20 mm versus ≤20 mm
Early Intervention for Psoriasis With Guselkumab Tied to Complete Response
Systemic responses seen across patient groups, but more complete skin clearance seen with short disease duration
Crohn's Disease More Common in People With Hidradenitis Suppurativa
Findings seen among pediatric patients aged 12 to 17 years
FDA Warns Against Using Bogus Treatments for Molluscum
Unapproved products are unlikely to actually have the impact they claim and may cause bad reactions
Spironolactone Found to Improve Acne in Adult Women
Mean quality-of-life symptoms favor spironolactone at 12 and 24 weeks; more participants report acne improvement with spironolactone
Is Low Vitamin D Tied to Psoriasis Exacerbation After COVID-19 Vaccination?
Higher rates of exacerbation after COVID-19 vaccination seen for patients with psoriasis and low vitamin D levels
What Is the Risk for Mortality After Diagnosis of Melanoma in Situ?
Researchers find 15-year relative survival to be 112.4 percent and all-cause standardized mortality ratio to be 0.68
More Mpox Cases Reported as Health Officials Fear a Summer Resurgence
U.S. cases are still at less than three per day, with 32 infections diagnosed in May so far
Atopic Dermatitis Tied to Higher Venous Thromboembolism Risk
While absolute risk difference is small, higher risk seen for both deep vein thrombosis and pulmonary embolism
Are Biosimilars Efficacious, Safe for Psoriasis Treatment?
Review finds no clinically or statistically significant difference in rates of achieving PASI-75 or adverse events for biosimilars, originator biologics
Does UVB Phototherapy Increase Risk for Skin Cancer in Patients With Eczema?
No increase seen in skin cancer, nonmelanoma skin cancer, cutaneous melanoma for those treated with UVB phototherapy
Is Tirbanibulin Effective for Treating Actinic Keratosis?
Improvement seen in Skindex-16 quality-of-life scores in symptoms, emotions, functioning domains at week 8 with tirbanibulin
Do Patients With Melasma Have Lower Levels of Serum Vitamin D?
Average serum calcidiol 33.8 ± 15.8 ng/mL seen in patients with melasma versus 36.8 ± 15.8 ng/mL in other dermatology patients
Microdosed Incisional Clindamycin Cuts SSI After Skin Cancer Surgery
Significantly fewer lesions receiving microdosed clindamycin, flucloxacillin required postoperative systemic antibiotics
JYNNEOS Vaccine Seems Effective for Preventing Mpox
Two-dose series offers better protection, with vaccine effectiveness of 66.0 percent compared with 35.8 percent for one-dose
Is Oxymetazoline Effective for Persistent Facial Erythema of Rosacea?
Clinician Erythema Assessment success rate significantly higher after oxymetazoline treatment versus vehicle
Hyaluronic Acid-Based Filler Produces Midface Volume Restoration
Benefit persists for 540 days in some individuals, even without retouch
Domestic Abuse Tied to Higher Risk for New Atopic Disease
Higher risk seen for asthma, atopic eczema, and allergic rhinoconjunctivitis
24 of 1292